Conventional brain MRI in neuromyelitis optica

European Journal of Neurology

Volumn 19, Issue 6, 2012, Pages 812-819

  Cabrera Gomez, J A ^a   Kister, I ^b  

^a Cuban Multiple Sclerosis Society   (Cuba)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aquaporin 4; Case series; Magnetic resonance imagining; Neuromyelitis optica; Review

Indexed keywords

BRAIN DISEASE; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; HUMAN; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW;

BRAIN; DATABASES, FACTUAL; HUMANS; MAGNETIC RESONANCE IMAGING; NEUROMYELITIS OPTICA;

EID: 84860920076     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03565.x     Document Type: Review

References (59)

1. Waters P, Vincent A. Detection of anti-aquaporin-4 antibodies in neuromyelitis optica: current status of the assays. Int MS J 2008; 15: 99-105.
2. Bradl M, Lassmann DH. Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance? Int MS J 2008; 15: 75-78.
3. Saikali P, Cayrol R, Vincent T. Anti-aquaporin-4 auto-antibodies orchestrate the pathogenesis in neuromyelitis optica. Autoimmun Rev 2009; 9: 132-135.
4. Parratt JDE, Prineas JW. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Mult Scler 2010; 16: 1156-1172.
5. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003; 4: 991-1001.
6. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004; 364: 2106-2112.
7. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
8. Sellner J, Boggild M, Clanet M, et al. EFNS guidelines on diagnosis and management of neuromyelitis optica. Eur J Neurol 2010; 17: 1019-1032.
9. Mandler RN, Davis LE, Jeffery DR, Kornfeld M. Devic's neuromyelitis optica: a clinicopathological study of 8 patients. Ann Neurol 1993; 34: 162-168.
10. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's neuromyelitis optica. J Neurol Neurosurg Psychiatry 1996; 60: 382-387.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999; 53: 1107-1114.
12. Cabre P, Heinzlef O, Merle H, et al. Multiple sclerosis and neuromyelitis optica in Martinique. Neurology 2001; 56: 507-514.
13. Modi G, Mochan A, Modi M, Saffer D. Demyelinating disorder of the central nervous system occurring in black South Africans. J Neurol Neurosurg Psychiatry 2001; 70: 500-505.
14. Alvarenga R, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002; 73: 429-435.
15. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chantel M, Vermersch P. Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosis Mult Scler 2003; 9: 521-525.
16. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004; 25: 47-52.
17. Pittock SJ, Lennon VA, Krecke K, et al. Brain abnormalities in neuromyelitis optica. Arch Neurol 2006; 63: 390-396.
18. Cabrera-Gomez JA, Quevedo-Sotolongo L, Gonzalez-Quevedo A, et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis. Mult Scler 2007; 13: 186-192.
19. Li Y, Xie P, Lu F, et al. Brain magnetic resonance imaging abnormalities in neuromyelitis optica. Acta Neurol Scand 2008; 118: 218-225.
20. Lekha P. Neuromyelitis optica antibody (NMO-IgG) status in Indian patients with multiple sclerosis and allied demyelinating disorders. Neurology Asia 2008; 13: 175-178.
21. Bichuetti DB, Oliveira EML, Souza NA, et al. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors. Mult Scler 2009; 15: 613-619.
22. Wang F, Liu Y, Duan Y, et al. Brain MRI abnormalities in neuromyelitis optica. Eur J Radiol 2010; doi: 10.1016/j.ejrad.2010.06.024 [Epub ahead of print].
23. Lu Z, Qiu W, Zou Y, et al. Characteristic linear lesions and longitudinally extensive spinal cord lesions in Chinese patients with neuromyelitis optica. J Neurol Sci 2010; 293: 92-96.
24. Min JH, Song P, Kim RJ, et al. Acute phase MRI features of brain lesions characteristics of neuromyelitis optica. Mult Scler 2010; 16: S197-S352.
25. Matsushita T, Isobe N, Piao H, et al. Reappraisal of brain MRI features in patients with multiple sclerosis and neuromyelitis optica according to anti-aquaporin-4 antibody status. J Neurol Sci 2010; 291: 37-43.
26. Sahraian MA, Moinfar Z, Khorramnia S, Ebrahim MM. Relapsing neuromyelitis optica: demographic and clinical features in Iranian patients. Eur J Neurol 2010; 17: 794-799.
27. Collongues N, Marignier R, Zéphir H, et al. Neuromyelitis optica in France: a multicenter study of 125 patients. Neurology 2010; 74: 736-774.
28. Asgari N, Lillevang ST, Skejoe HP, Falah M, Stenager E, Kyvik KO. A population-based study of neuromyelitis optica in Caucasians. Neurology 2011; 76: 1589-1595.
29. Kim JE, Kim SM, Ahn SW, et al. Brain abnormalities in neuromyelitis optica. J Neurol Sci 2011; 302: 43-48.
30. Chotik-anuchit S, Siritho S, Tritrakarn SO, Chawalprit O, Prayoonwiwat N. Optic-Spinal Inflammatory Demyelinating Disease: (OS-IDD) patients in Siriraj Hospital. J Med Assoc Thai 2011; 94: 27-35.
31. Lotze TE, Northrop JL, Hutton GJ, et al. Spectrum of pediatric neuromyelitis optica. Pediatrics 2008; 122: 1039-1047.
32. Banwell B, Tenembaum S, Lennon V, et al. Neuromyelitis optica in childhood inflammatory demyelinating CNS disorders. Neurology 2008; 70: 344-352.
33. McKeon A, Lennon VA, Lotze T, et al. CNS aquaporin-4 autoimmunity in children. Neurology 2008; 71: 93-100.
34. Collongues N, Marignier R, Zéphir H, et al. Long-term follow-up of neuromyelitis optica with a pediatric onset. Neurology 2010; 75: 1084-1088.
35. Huppke P, Blüthner M, Bauer O, et al. Neuromyelitis optica and NMO-IgG in European pediatric patients. Neurology 2010; 75: 1740-1744.
36. Peña J, Ravelo ME, Mora-La Cruz E, Montiel-Nava C. NMO in pediatric patients: brain involvement and clinical expression. Arq Neuropsiquiatr 2011; 69: 34-38.
37. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG. J Neurol Neurosurg Psychiatr 2006; 77: 1073-1075.
38. Ito S, Mori M, Makino T, et al. "Cloud-like enhancement" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol 2009; 66: 425-428.
39. Kister I, Howard J, Perumal J, et al. Brain MRI in a series of NMO-IgG seropositive patients. Mult Scler 2010; 16: S7-S39.
40. Kim W, Park MS, Lee SH, et al. Characteristic brain magnetic resonance imaging abnormalities in central nervous system aquaporin-4 autoimmunity. Mult Scler 2010; 16: 1229-1236.
41. Downer JJ, Leite MI, Carter R, Palace J, Küker W, Quaghebeur G. Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete? Neuroradiology 2011; doi: 10.1007/S00234-011-0875-x [Epub ahead of print].
42. Pittock SJ, Weinshenker BG, Lucchinetti CF, et al. Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol 2006; 63: 964-968.
43. Matsuhita T, Matsouka T, Ishizu T, et al. Anterior ventricular linear lesions in optic-spinal multiple sclerosis: a combined neuroimaging and neuropathological study. Mult Scler 2008; 14: 343-353.
44. Vernant JC, Cabre P, Smadja D, et al. Recurrent optic neuromyelitis with endocrinopathies: a new syndrome. Neurology 1997; 48: 58-64.
45. Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol 2010; 68: 757-761.
46. Nakamura M, Miyazawa I, Fujihara K, et al. Preferential spinal central gray matter involvement in neuromyelitis optica. An MRI study. J Neurol 2008; 255: 163-170.
47. Nakamura M, Misu T, Fujihara K, et al. Occurrence of acute large and edematous callosal lesions in neuromyelitis optica. Mult Scler 2009; 15: 695-700.
48. Magaña SM, Matiello M, Pittock SJ, et al. Posterior reversible encephalopathy syndrome in neuromyelitis optica spectrum disorders. Neurology 2009; 72: 712-717.
49. Cabrera-Gómez JA, Saiz-Hinarejos A, Graus F, et al. Brain magnetic resonance imaging findings in acute relapses of neuromyelitis optica spectrum disorders. Mult Scler 2008; 14: 248-251.
50. Simon JH, Li D, Traboulsee T, et al. Standardized MR imaging protocol for multiple sclerosis: Consortium of Multiple Sclerosis Centers consensus guidelines. AJNR Am J Neuroradiol 2001; 27: 455-461.
51. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology 1988; 38: 180-185.
52. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007; 6: 677-686.
53. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997; 120: 2059-2069.
54. Radaelli M, Dalla Libera D, Moiola L, et al. Relapsing neuromyelitis optica: clinical characteristics and identification of prognostic factors. Mult Scler 2010; 16: S47.
55. Cabrera-Gómez JA, Bonnan M, González-Quevedo A, et al. Neuromyelitis optica positive antibodies confer a worse course in relapsing-neuromyelitis optica in Cuba and French West Indies. Mult Scler 2009; 15: 828-833.
56. Popescu BFG, Parisi JE, Cabrera-Gómez JA, et al. Absence of cortical demyelination in neuromyelitis optica. Neurology 2010; 75: 2103-2109.
57. Fisher E, Lee JC, Nakamura K. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-265.
58. de Seze J, Chanson JB, Collongues N, et al. Brain MRI volume evaluation in clinically isolated syndrome, multiple sclerosis and neuromyelitis optica. Neurology 2011; 76: S4A.
59. Graber JJ, Kister I, Geyer H, et al. Neuromyelitis optica and concentric rings of Balo in the brainstem. Arch Neurol 2009; 66: 274-275.